WEBSITE BSE:544512 NSE: SHRINGARMS Inc. Year: 2009 Industry: Diamond & Jewellery My Bucket: Add Stock
Last updated: 15:57
Shringar House of Mangalsutra Ltd. is a dedicated Indian jewellery firm that designs, manufactures, and supplies a range of mangalsutras (traditional Indian jewellery worn by married women) made from 18k or 22k gold, typically accented with cubic zirconia, pearls, American diamonds, or semi-precious stones. The company was incorporated in 2009, and is currently in the process of becoming a public limited company. Shringar primarily operates on a B2B basis with corporate clients (such as Titan, Reliance Retail, and Malabar Gold), wholesalers, an...Read More
Shringar House of Mangalsutra Ltd. is a dedicated Indian jewellery firm that designs, manufactures, and supplies a range of mangalsutras (traditional Indian jewellery worn by married women) made from 18k or 22k gold, typically accented with cubic zirconia, pearls, American diamonds, or semi-precious stones. The company was incorporated in 2009, and is currently in the process of becoming a public limited company. Shringar primarily operates on a B2B basis with corporate clients (such as Titan, Reliance Retail, and Malabar Gold), wholesalers, and retailers. The company has a design catalogue of over 10,000 SKUs across 15 collections, which is supported by 22 in-house designers and 166 artisans. In terms of financial performance, Shringar has also experienced strong growth; for FY25, Shringar reported revenue of ₹1,429.8 crore and a PAT of ₹61.11 crore, a significant increase from previous years. Shringar has a pan-India presence across 24 states and 4 Union Territories, and also exports to the UK, UAE, New Zealand, USA, and Fiji. The company intends to raise funds through an IPO for working capital and general corporate purposes. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1949 Cr.
Stock P/E 31.9
P/B 3
Current Price ₹202.1
Book Value ₹ 66.5
Face Value 10
52W High ₹266.4
Dividend Yield 0%
52W Low ₹ 165.8
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Net Sales | 271 | 416 | 391 | 333 | 529 | 659 |
| Other Income | 0 | 0 | 0 | 0 | 1 | 2 |
| Total Income | 271 | 416 | 391 | 333 | 529 | 661 |
| Total Expenditure | 246 | 392 | 372 | 291 | 496 | 619 |
| Operating Profit | 25 | 24 | 20 | 41 | 33 | 42 |
| Interest | 2 | 2 | 2 | 2 | 2 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 23 | 22 | 17 | 38 | 30 | 40 |
| Provision for Tax | 6 | 6 | 4 | 10 | 7 | 10 |
| Profit After Tax | 17 | 16 | 13 | 29 | 23 | 30 |
| Adjustments | -0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 17 | 16 | 13 | 29 | 23 | 30 |
| Adjusted Earnings Per Share | 2.4 | 2.2 | 1.8 | 4 | 2.4 | 3.1 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 810 | 950 | 1102 | 1430 | 1912 |
| Other Income | 1 | 1 | 1 | 0 | 3 |
| Total Income | 811 | 951 | 1103 | 1430 | 1914 |
| Total Expenditure | 780 | 912 | 1052 | 1337 | 1778 |
| Operating Profit | 31 | 39 | 51 | 93 | 136 |
| Interest | 3 | 6 | 6 | 8 | 7 |
| Depreciation | 1 | 2 | 3 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 27 | 31 | 42 | 82 | 125 |
| Provision for Tax | 7 | 8 | 11 | 21 | 31 |
| Profit After Tax | 20 | 23 | 31 | 61 | 95 |
| Adjustments | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 20 | 23 | 31 | 61 | 95 |
| Adjusted Earnings Per Share | 2.9 | 3.3 | 4.4 | 8.5 | 11.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 30% | 21% | 0% | 0% |
| Operating Profit CAGR | 82% | 44% | 0% | 0% |
| PAT CAGR | 97% | 45% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 36% | 29% | 28% | 28% |
| ROCE Average | 32% | 25% | 23% | 23% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 82 | 106 | 137 | 201 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 34 | 17 | 6 | 3 |
| Other Non-Current Liabilities | 5 | 4 | 3 | 2 |
| Total Current Liabilities | 75 | 85 | 119 | 170 |
| Total Liabilities | 195 | 212 | 265 | 376 |
| Fixed Assets | 20 | 20 | 18 | 19 |
| Other Non-Current Assets | 32 | 33 | 37 | 32 |
| Total Current Assets | 144 | 159 | 210 | 325 |
| Total Assets | 195 | 212 | 265 | 376 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 5 | 6 | 2 |
| Cash Flow from Operating Activities | -30 | 13 | -15 | -7 |
| Cash Flow from Investing Activities | -36 | -3 | -1 | -3 |
| Cash Flow from Financing Activities | 69 | -9 | 12 | 9 |
| Net Cash Inflow / Outflow | 3 | 1 | -4 | -1 |
| Closing Cash & Cash Equivalent | 5 | 6 | 2 | 1 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.86 | 3.29 | 4.38 | 8.47 |
| CEPS(Rs) | 2.95 | 3.55 | 4.75 | 8.84 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 11.6 | 14.89 | 19.28 | 27.84 |
| Core EBITDA Margin(%) | 3.72 | 3.99 | 4.51 | 6.46 |
| EBIT Margin(%) | 3.72 | 3.92 | 4.39 | 6.3 |
| Pre Tax Margin(%) | 3.37 | 3.31 | 3.83 | 5.72 |
| PAT Margin (%) | 2.5 | 2.46 | 2.82 | 4.27 |
| Cash Profit Margin (%) | 2.58 | 2.65 | 3.06 | 4.46 |
| ROA(%) | 10.37 | 11.48 | 13.05 | 19.08 |
| ROE(%) | 24.63 | 24.86 | 25.67 | 36.2 |
| ROCE(%) | 17.17 | 20.09 | 22.04 | 31.85 |
| Receivable days | 11.57 | 13.96 | 17.8 | 18.92 |
| Inventory Days | 49.97 | 41.23 | 41.02 | 47.47 |
| Payable days | 3.37 | 2.04 | 2.15 | 7.32 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.12 | 0.1 | 0.1 | 0.13 |
| EV/Core EBITDA(x) | 3.15 | 2.35 | 2.2 | 2.05 |
| Net Sales Growth(%) | 0 | 17.28 | 15.92 | 29.8 |
| EBIT Growth(%) | 0 | 23.56 | 29.95 | 86.32 |
| PAT Growth(%) | 0 | 15.26 | 33.17 | 96.48 |
| EPS Growth(%) | 0 | 15.26 | 33.17 | 93.22 |
| Debt/Equity(x) | 1.13 | 0.84 | 0.78 | 0.6 |
| Current Ratio(x) | 1.93 | 1.88 | 1.76 | 1.91 |
| Quick Ratio(x) | 0.44 | 0.65 | 0.55 | 0.57 |
| Interest Cover(x) | 10.8 | 6.45 | 7.82 | 10.88 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoter | 74.8 | 74.8 | 74.8 | 74.8 |
| FII | 4.67 | 3.95 | 3.36 | 5.78 |
| DII | 6.41 | 2.85 | 1.37 | 1.35 |
| Public | 14.12 | 18.4 | 20.46 | 18.07 |
| Others | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 |
| # | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoter | 7.21 | 7.21 | 7.21 | 7.21 |
| FII | 0.45 | 0.38 | 0.32 | 0.56 |
| DII | 0.62 | 0.28 | 0.13 | 0.13 |
| Public | 1.36 | 1.77 | 1.97 | 1.74 |
| Others | 0 | 0 | 0 | 0 |
| Total | 9.64 | 9.64 | 9.64 | 9.64 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.